Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

MR-TRUS fusion biopsy—defining a new standard

Nature Reviews Clinical Oncology volume 12, pages 253–254 (2015)Cite this article

Subjects

The widespread use of PSA screening and transrectal ultrasound (TRUS)-guided prostate biopsy has resulted in an epidemic of overdetection and overtreatment of prostate cancer. The use of targeted magnetic resonance (MR) and ultrasound fusion guided prostate biopsy promises to improve the detection rate of high-risk prostate cancer—reducing the issue of overdetection and overtreatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Klein, E. A. & Zippe, C. D. Transrectal ultrasound guided prostate biopsy—defining a new standard. J. Urol. 163, 179–180 (2000).

    Article  CAS  Google Scholar 

  2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2015. CA Cancer J. Clin. 65, 5–29 (2015).

    Article  Google Scholar 

  3. Pinsky, P. F. et al. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. BJU Int. 99, 775–779 (2007).

    Article  CAS  Google Scholar 

  4. Siddiqui, M. M. et al. Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313, 390–397 (2015).

    Article  CAS  Google Scholar 

  5. Sonn, G. A. et al. Targeted biopsy in the detection of prostate cancer using an office-based MR-US fusion device. J. Urol. 189, 86–91 (2013).

    Article  Google Scholar 

  6. Pokorny, M. R. et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound–guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur. Urol. 66, 22–29 (2014).

    Article  Google Scholar 

  7. Klein, E. A. et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur. Urol. 66, 550–560 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic Lerner College of Medicine, Mail Code Q10-1, 9500 Euclid Avenue, Cleveland, 44195, OH, USA

    Eric A. Klein

Authors
  1. Eric A. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric A. Klein.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klein, E. MR-TRUS fusion biopsy—defining a new standard. Nat Rev Clin Oncol 12, 253–254 (2015). https://doi.org/10.1038/nrclinonc.2015.70

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2015.70

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer